Christelle Clément-Duchêne

Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study

Benjamin Besse, Sylvestre Le Moulec, Julien Mazières et al. · Clinical Cancer Research · 2015 · 227 citations

Medicine, Oncology, Pharmacology +17

Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC.

David R. Spigel, Thomas J. Ervin, Rodryg Ramlau et al. · Journal of Clinical Oncology · 2011 · 194 citations

Medicine, Oncology, Pharmacology +15

Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort

Claire Merveilleux du Vignaux, Éric Dansin, Laurent Mhanna et al. · Journal of Thoracic Oncology · 2018 · 84 citations

Medicine, Oncology, Pathology +12

Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors

Quentin Giordan, Julia Salleron, Catherine Vallance et al. · Frontiers in Immunology · 2021 · 81 citations · Full text

Medicine, Oncology, Pharmacology +15

CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features

Rania Elakoum, Guillaume Gauchotte, Abderrahim Oussalah et al. · Biochimie · 2013 · 75 citations

Medicine, Molecular Biology, Oncology +13